Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma-Reference-Cited by-同舟云学术

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Published:2022-09-20 Issue:4 Volume:12 Page:3999-4009
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Mateos María Victoria¹^ORCID,Prosper Felipe²³^ORCID,Martin Sánchez Jesús⁴^ORCID,Ocio Enrique M.¹⁵,Oriol Albert⁶,Motlló Cristina⁶,Michot Jean‐Marie⁷^ORCID,Jarque Isidro⁸,Iglesias Rebeca⁹,Solé María⁴,Martínez Sara¹⁰,Kahatt Carmen¹⁰,Fudio Salvador¹⁰,Corral Gema¹⁰,Zeaiter Ali¹⁰,Montilla Lola¹⁰,Ribrag Vincent⁷

Affiliation:

1. Hospital Universitario de Salamanca Salamanca Spain

2. Clínica Universidad de Navarra Pamplona Spain

3. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Instituto de Salud Carlos III Madrid Spain

4. Hospital Universitario Virgen del Rocio Sevilla Spain

5. Hospital Universitario Marqués de Valdecilla (IDIVAL) Universidad de Cantabria Santander Spain

6. Institut Català d'Oncologia Hospital Germans Trias i Pujol Badalona Spain

7. Institut Gustave Roussy Villejuif France

8. Hospital Universitario La Fe Valencia Spain

9. M.D. Anderson Cancer Center Madrid Spain

10. PharmaMar Madrid Spain

Funder

PharmaMar

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5250

Reference34 articles.

1. International Myeloma Working Group recommendations for global myeloma care

2. National Cancer Institute Surveillance.Epidemiology and End Results Program. SEER stat fact sheets: myeloma;2022.http://seer.cancer.gov/statfacts/html/mulmy.html

3. Multiple myeloma: patient outcomes in real‐world practice

4. Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

5. Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies;Marine Drugs;2024-02-28

2. Pharmacology of marine drugs: Pattern-, purpose- and prudence-driven innovations;Annual Reports in Medicinal Chemistry;2023